Chua BY - Search Results

1

Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.

Mangas KM, Buultjens AH, Porter JL, Baines SL, Marion E, Marsollier L, Tobias NJ, Pidot SJ, Quinn KM, Price DJ, Kedzierska K, Zeng W, Jackson DC, Chua BY, Stinear TP. Mangas KM, et al. Among authors: chua by. Infect Immun. 2020 Feb 20;88(3):e00753-19. doi: 10.1128/IAI.00753-19. Print 2020 Feb 20. Infect Immun. 2020. PMID: 31818964 Free PMC article.

2

Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.

Chua BY, Healy A, Cameron PU, Stock O, Rizkalla M, Zeng W, Torresi J, Brown LE, Fowler NL, Gowans EJ, Jackson DC. Chua BY, et al. Immunol Cell Biol. 2003 Feb;81(1):67-72. doi: 10.1046/j.1440-1711.2003.01133.x. Immunol Cell Biol. 2003. PMID: 12534949

3

Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups.

Chua BY, Zeng W, Lau YF, Jackson DC. Chua BY, et al. Vaccine. 2007 Jan 2;25(1):92-101. doi: 10.1016/j.vaccine.2006.07.012. Epub 2006 Jul 31. Vaccine. 2007. PMID: 17055123

4

Dendritic cell acquisition of epitope cargo mediated by simple cationic peptide structures.

Chua BY, Eriksson EM, Poole DP, Zeng W, Jackson DC. Chua BY, et al. Peptides. 2008 Jun;29(6):881-90. doi: 10.1016/j.peptides.2008.01.025. Epub 2008 Mar 10. Peptides. 2008. PMID: 18378356

5

A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection.

Chua BY, Eriksson EM, Brown LE, Zeng W, Gowans EJ, Torresi J, Jackson DC. Chua BY, et al. Vaccine. 2008 Sep 2;26(37):4866-75. doi: 10.1016/j.vaccine.2008.03.032. Epub 2008 Apr 7. Vaccine. 2008. PMID: 18455278 Free PMC article.

6

Synthesis of toll-like receptor-2 targeting lipopeptides as self-adjuvanting vaccines.

Chua BY, Zeng W, Jackson DC. Chua BY, et al. Methods Mol Biol. 2008;494:247-61. doi: 10.1007/978-1-59745-419-3_14. Methods Mol Biol. 2008. PMID: 18726578

7

Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys.

Zeng W, Eriksson E, Chua B, Grollo L, Jackson DC. Zeng W, et al. Amino Acids. 2010 Jul;39(2):471-80. doi: 10.1007/s00726-009-0463-0. Epub 2010 Jan 21. Amino Acids. 2010. PMID: 20091415

8

Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2.

Chua BY, Pejoski D, Turner SJ, Zeng W, Jackson DC. Chua BY, et al. J Immunol. 2011 Aug 15;187(4):1692-701. doi: 10.4049/jimmunol.1100486. Epub 2011 Jul 8. J Immunol. 2011. PMID: 21742967

9

Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines.

Chua BY, Al Kobaisi M, Zeng W, Mainwaring D, Jackson DC. Chua BY, et al. Mol Pharm. 2012 Jan 1;9(1):81-90. doi: 10.1021/mp200264m. Epub 2011 Dec 16. Mol Pharm. 2012. PMID: 22149016

10

Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake.

Al Kobiasi M, Chua BY, Tonkin D, Jackson DC, Mainwaring DE. Al Kobiasi M, et al. Among authors: chua by. J Biomed Mater Res A. 2012 Jul;100(7):1859-67. doi: 10.1002/jbm.a.34153. Epub 2012 Apr 4. J Biomed Mater Res A. 2012. PMID: 22488776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters